These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 3816491)

  • 41. [Controlled trial of intravenous lyophilized indomethacin in the treatment of persistent ductus arteriosus in premature infants].
    Monset-Couchard M; Dias-Mançano D; Murat I; Relier JP
    Pediatrie; 1983 Sep; 38(6):365-77. PubMed ID: 6364030
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effectiveness and side effects of an escalating, stepwise approach to indomethacin treatment for symptomatic patent ductus arteriosus in premature infants below 33 weeks of gestation.
    Sperandio M; Beedgen B; Feneberg R; Huppertz C; Brüssau J; Pöschl J; Linderkamp O
    Pediatrics; 2005 Dec; 116(6):1361-6. PubMed ID: 16322159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparison of ibuprofen and indometacin for early-targeted treatment of patent ductus arteriosus in extremely premature infants: a randomised controlled trial.
    Su BH; Lin HC; Chiu HY; Hsieh HY; Chen HH; Tsai YC
    Arch Dis Child Fetal Neonatal Ed; 2008 Mar; 93(2):F94-9. PubMed ID: 17768157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Atrial natriuretic peptide in the diagnosis of patent ductus arteriosus.
    Weir FJ; Smith A; Littleton P; Carter N; Hamilton PA
    Acta Paediatr; 1992 Sep; 81(9):672-5. PubMed ID: 1421905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Closure of persistent ductus arteriosus in premature infants by drug therapy].
    Hencz P; Kertész E; Beviz J; Szeleczki T; Szekeres Z
    Orv Hetil; 1981 Oct; 122(41):2535-40. PubMed ID: 7033879
    [No Abstract]   [Full Text] [Related]  

  • 46. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels.
    Yeh TF; Achanti B; Patel H; Pildes RS
    Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [An alternative in the management of patent ductus arteriosus using indomethacin in premature newborn infants].
    Lozano González CH; Holden AM; Hurtado del Río D; Segura MA
    Bol Med Hosp Infant Mex; 1982 Aug; 39(8):570-5. PubMed ID: 7182006
    [No Abstract]   [Full Text] [Related]  

  • 48. Indomethacin therapy in premature infants with patent ductus arteriosus.
    Rasidi C; Madiyono B; Usman IN
    Paediatr Indones; 1982; 22(3-4):70-6. PubMed ID: 7122105
    [No Abstract]   [Full Text] [Related]  

  • 49. [Patent ductus arteriosus in premature newborns. Treatment with indomethacin (author's transl)].
    Marchal F; Monin P; Vert P; Bianchetti G; Morselli PL
    Arch Fr Pediatr; 1981; 38(7):503-8. PubMed ID: 7283656
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Drug therapy of patent ductus arteriosus in premature and newborn infants].
    Bartel J
    Kinderarztl Prax; 1978 Dec; 46(12):644-8. PubMed ID: 366238
    [No Abstract]   [Full Text] [Related]  

  • 51. Role of indomethacin in ductus closure: an update evaluation.
    Douidar SM; Richardson J; Snodgrass WR
    Dev Pharmacol Ther; 1988; 11(4):196-212. PubMed ID: 3066603
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effects of indomethacin on renal function and intracranial hemorrhage in infants with patent ductus arteriosus.
    Davis JM; Hendricks-Munoz KD; Hagberg D; Manning JA
    Dev Pharmacol Ther; 1990; 14(1):15-9. PubMed ID: 2311476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nonsurgical closure of patent ductus arteriosus in preterm infants.
    Smith ME
    Heart Lung; 1979; 8(2):308-10. PubMed ID: 253708
    [No Abstract]   [Full Text] [Related]  

  • 54. Sepsis and indomethacin failure in premature infants with symptomatic patent ductus arteriosus.
    Salzer HR; Salzer-Muhar U; Pollak A; Weninger M
    Lancet; 1987 Apr; 1(8539):977. PubMed ID: 2882363
    [No Abstract]   [Full Text] [Related]  

  • 55. [Indomethacin treatment of persistent ductus arteriosus in premature infants].
    Petersen S; Christensen NC; Lauridsen P; Pedersen SA; Ryssing E
    Ugeskr Laeger; 1983 Nov; 145(46):3564-7. PubMed ID: 6649140
    [No Abstract]   [Full Text] [Related]  

  • 56. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Indomethacin and renal function in premature infants with persistent patent ductus arteriosus.
    Cifuentes RF; Olley PM; Balfe JW; Radde IC; Soldin SJ
    J Pediatr; 1979 Oct; 95(4):583-7. PubMed ID: 480039
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Pharmacologic treatment of patent ductus arteriosus in premature infants].
    Vázquez C; Cabrera A; Pastor E; Valls y Soler A
    An Esp Pediatr; 1983 Jun; 18(6):482-8. PubMed ID: 6625369
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Intravenous indomethacin therapy in premature infants with patent ductus arteriosus. Causes of death and one-year follow-up.
    Yeh TF; Goldbarg HR; Henek T; Thalji A; Pildes RS
    Am J Dis Child; 1982 Sep; 136(9):803-7. PubMed ID: 7114004
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus.
    Kluckow M; Jeffery M; Gill A; Evans N
    Arch Dis Child Fetal Neonatal Ed; 2014 Mar; 99(2):F99-F104. PubMed ID: 24317704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.